{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:38:41Z","timestamp":1780083521470,"version":"3.54.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05170-w","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:05:01Z","timestamp":1742371501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary ovarian neuroendocrine neoplasia with concurrent large epithelial borderline ovarian tumor, coexistent with non-malignant pleural effusion and multiple uterine fibroids: a case report and review of the literature"],"prefix":"10.1186","volume":"19","author":[{"given":"Mariam","family":"Mohsin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-6162","authenticated-orcid":false,"given":"Rajani","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavra","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"3","key":"5170_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.rcl.2011.02.011","volume":"49","author":"MT Heller","year":"2011","unstructured":"Heller MT, Shah AB. Imaging of neuroendocrine tumors. Radiol Clin North Am. 2011;49(3):529\u201348. https:\/\/doi.org\/10.1016\/j.rcl.2011.02.011.","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"5170_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","volume":"18","author":"CB Tempfer","year":"2018","unstructured":"Tempfer CB, Tischoff I, Dogan A, et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer. 2018;18(1):530. https:\/\/doi.org\/10.1186\/s12885-018-4447-x.","journal-title":"BMC Cancer"},{"issue":"03","key":"5170_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/PAS.0b013e3181ce1447","volume":"34","author":"DS Klimstra","year":"2010","unstructured":"Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010;34(03):300\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5170_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","volume":"122","author":"GJ Gardner","year":"2011","unstructured":"Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190\u20138.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"5170_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","volume":"19","author":"BE Howitt","year":"2017","unstructured":"Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017;19(9):59. https:\/\/doi.org\/10.1007\/s11912-017-0617-2.","journal-title":"Curr Oncol Rep"},{"key":"5170_CR6","unstructured":"Board WCoTE, Female Genital Tumours, 2020; 5(4). International Agency for Research on Cancer, Lyon (France)."},{"key":"5170_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5146\/tjpath.2015.01320","volume":"31","author":"M KeFel\u0130","year":"2015","unstructured":"KeFel\u0130 M, Usub\u00fct\u00fcn A. An update of neuroendocrine tumors of the female reproductive system. Turk Patoloji Derg. 2015;31:128\u201344. https:\/\/doi.org\/10.5146\/tjpath.2015.01320.","journal-title":"Turk Patoloji Derg"},{"key":"5170_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770\u201386. https:\/\/doi.org\/10.1038\/s41379-018-0110-y.","journal-title":"Mod Pathol"},{"issue":"1","key":"5170_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ygyno.2021.04.039","volume":"162","author":"I Winer","year":"2021","unstructured":"Winer I, Kim C, Gehrig P. Neuroendocrine tumors of the gynecologic tract update. Gynecol Oncol. 2021;162(1):210\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.039.","journal-title":"Gynecol Oncol"},{"key":"5170_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ygyno.2020.05.452","volume":"159","author":"EK Crane","year":"2020","unstructured":"Crane EK, Ramos P, Farley JH, et al. Molecular profiling in a large cohort of gynecologic neuroendocrine tumors. Gynecol Oncol. 2020;159:262. https:\/\/doi.org\/10.1016\/j.ygyno.2020.05.452.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"5170_CR11","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/cancers14071835","volume":"14","author":"M Virarkar","year":"2022","unstructured":"Virarkar M, Vulasala SS, Morani AC, et al. Neuroendocrine neoplasms of the gynecologic tract. Cancers (Basel). 2022;14(7):1835. https:\/\/doi.org\/10.3390\/cancers14071835.","journal-title":"Cancers (Basel)"},{"key":"5170_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","volume":"19","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, et al. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19:991\u20131002.","journal-title":"Neoplasia"},{"key":"5170_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1477-7819-12-314","volume":"12","author":"EY Ki","year":"2014","unstructured":"Ki EY, Park JS, Lee KH, et al. Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature. World J Surg Oncol. 2014;12:314. https:\/\/doi.org\/10.1186\/1477-7819-12-314.","journal-title":"World J Surg Oncol"},{"issue":"9","key":"5170_CR14","first-page":"1000","volume":"14","author":"P Gupta","year":"2021","unstructured":"Gupta P, Bagga R, Rai B, Srinivasan R. Primary pure large cell neuroendocrine carcinoma of the ovary: histopathologic and immunohistochemical analysis with review of the literature. Int J Clin Exp Pathol. 2021;14(9):1000\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"23","key":"5170_CR15","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.1002\/cam4.4368","volume":"10","author":"L Pang","year":"2021","unstructured":"Pang L, Guo Z. Primary neuroendocrine tumors of the ovary: management and outcomes. Cancer Med. 2021;10(23):8558\u201369. https:\/\/doi.org\/10.1002\/cam4.4368.","journal-title":"Cancer Med"},{"issue":"7","key":"5170_CR16","first-page":"698","volume":"3","author":"K Munstedt","year":"2013","unstructured":"Munstedt K, Estel R, Dreyer T, et al. Small cell ovarian carcinomas\u2014characterisation of two rare tumor entities. Geburtshilfe Frauenheilkd. 2013;3(7):698\u2013704.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5170_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000529838","volume":"16","author":"E Lee","year":"2023","unstructured":"Lee E, Park M. Primary ovarian neuroendocrine carcinoid tumor arising in a mature cystic teratoma. Case Rep Oncol. 2023;16:163\u20137. https:\/\/doi.org\/10.1159\/000529838.","journal-title":"Case Rep Oncol"},{"issue":"2","key":"5170_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0042-1744233","volume":"32","author":"S Saha","year":"2022","unstructured":"Saha S, Ghosh P, Mukherjee G, Roy A. Metastatic primary neuroendocrine tumor of ovary\u2014a rare presentation. Indian J Radiol Imaging. 2022;32(2):270\u20134. https:\/\/doi.org\/10.1055\/s-0042-1744233.","journal-title":"Indian J Radiol Imaging"},{"issue":"3","key":"5170_CR19","first-page":"271","volume":"19","author":"J Soga","year":"2000","unstructured":"Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res. 2000;19(3):271\u201380.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"5170_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/20742835.2020.1832776","volume":"12","author":"R Wadee","year":"2020","unstructured":"Wadee R, Beavon I, Smith T, et al. Primary ovarian neuroendocrine tumour arising in a benign mature cystic teratoma: a case report and literature review. Southern Afr J Gynaecol Oncol. 2020;12(2):23\u20136. https:\/\/doi.org\/10.1080\/20742835.2020.1832776.","journal-title":"Southern Afr J Gynaecol Oncol"},{"issue":"4","key":"5170_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.anndiagpath.2006.03.011","volume":"11","author":"I Pecorella","year":"2007","unstructured":"Pecorella I, Memeo L, Ciardi A, et al. An unusual case of colonic mixed adenoendocrine carcinoma: collision versus composite tumor. A case report and review of the literature. Ann Diagn Pathol. 2007;11(4):285\u201390. https:\/\/doi.org\/10.1016\/j.anndiagpath.2006.03.011.","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"5170_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/his.12988","volume":"69","author":"BA Clarke","year":"2016","unstructured":"Clarke BA, Witkowski L, Ton Nu TN, et al. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics. Histopathology. 2016;69(5):727\u201338. https:\/\/doi.org\/10.1111\/his.12988.","journal-title":"Histopathology"},{"issue":"2","key":"5170_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.18632\/oncotarget.6459","volume":"7","author":"S Fahiminiya","year":"2016","unstructured":"Fahiminiya S, Witkowski L, Nadaf J, et al. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid\/rhabdoid tumor. Oncotarget. 2016;7(2):1732\u201340. https:\/\/doi.org\/10.18632\/oncotarget.6459.","journal-title":"Oncotarget"},{"issue":"7","key":"5170_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/his.13177","volume":"70","author":"WG McCluggage","year":"2017","unstructured":"McCluggage WG, Witkowski L, Clarke BA, Foulkes WD. Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm. Histopathology. 2017;70(7):1147\u201354. https:\/\/doi.org\/10.1111\/his.13177.","journal-title":"Histopathology"},{"issue":"5","key":"5170_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.2931","volume":"46","author":"L Witkowski","year":"2014","unstructured":"Witkowski L, Carrot-Zhang J, Albrecht S, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014;46(5):438\u201343. https:\/\/doi.org\/10.1038\/ng.2931.","journal-title":"Nat Genet"},{"issue":"2","key":"5170_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","volume":"9","author":"L Witkowski","year":"2016","unstructured":"Witkowski L, Goudie C, Foulkes WD, McCluggage WG. Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis. Surg Pathol Clin. 2016;9(2):215\u201326. https:\/\/doi.org\/10.1016\/j.path.2016.01.005.","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"5170_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/01.pas.0000213422.53750.d1","volume":"31","author":"E Veras","year":"2007","unstructured":"Veras E, Deavers MT, Silva EG, et al. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol. 2007;31(5):774\u201382. https:\/\/doi.org\/10.1097\/01.pas.0000213422.53750.d1.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5170_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13048-019-0543-z","volume":"12","author":"X Yang","year":"2019","unstructured":"Yang X, Chen J, Dong R. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature. J Ovarian Res. 2019;12(1):69. https:\/\/doi.org\/10.1186\/s13048-019-0543-z.","journal-title":"J Ovarian Res"},{"issue":"09 Suppl 3","key":"5170_CR29","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/IGC.0000000000000265","volume":"24","author":"NS Reed","year":"2014","unstructured":"Reed NS, Gomez-Garcia E, Gallardo-Rincon D, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. Int J Gynecol Cancer. 2014;24(09 Suppl 3):S35\u201341.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"5170_CR30","first-page":"649","volume":"51","author":"T Lenicek","year":"2012","unstructured":"Lenicek T, Tomas D, Soljaci\u0107-Vranes H, et al. Strumal carcinoid of the ovary: report of two cases. Acta Clin Croat. 2012;51(4):649\u201353.","journal-title":"Acta Clin Croat"},{"key":"5170_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s12905-02-02722-4","volume":"23","author":"BJ Feng","year":"2023","unstructured":"Feng BJ, Li TH, Li YH, et al. Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features. BMC Womens Health. 2023;23:595. https:\/\/doi.org\/10.1186\/s12905-02-02722-4.","journal-title":"BMC Womens Health"},{"issue":"2","key":"5170_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5603\/EP.2017.0015","volume":"68","author":"B Kos-Kud\u0142a","year":"2017","unstructured":"Kos-Kud\u0142a B, Blicharz-Dorniak J, Strzelczyk J. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the polish network of neuroendocrine tumours). Endokrynol Pol. 2017;68(2):79\u2013110. https:\/\/doi.org\/10.5603\/EP.2017.0015.","journal-title":"Endokrynol Pol"},{"key":"5170_CR33","unstructured":"WHO Classification of Tumours Editorial Board. Digestive System Tumours. In: WHO Classification of Tumours, 5th. Lyon, France: IARC Press; 2019."},{"key":"5170_CR34","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fendo.2021.770266","volume":"12","author":"M Opali\u0144ska","year":"2021","unstructured":"Opali\u0144ska M, Sowa-Staszczak A, Olearska H, et al. Clinical approach to neuroendocrine neoplasm associated with ovarian teratoma. Front Endocrinol. 2021;12:2021. https:\/\/doi.org\/10.3389\/fendo.2021.770266.","journal-title":"Front Endocrinol"},{"issue":"Suppl 2","key":"5170_CR35","first-page":"145A","volume":"29","author":"D Alkapalan","year":"2016","unstructured":"Alkapalan D, Maxwell JE, O\u2019Dorisio TM, et al. Prospective experience with routine SSTR2A immunohistochemistry in neuroendocrine epithelial neoplasms. Modern Pathol. 2016;29(Suppl 2):145A.","journal-title":"Modern Pathol"},{"key":"5170_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","volume":"96","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2019.12.002.","journal-title":"Hum Pathol"},{"issue":"9","key":"5170_CR37","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2967\/jnumed.117.191197","volume":"58","author":"MM Graham","year":"2017","unstructured":"Graham MM, Gu X, Ginader T, et al. 68Ga-DOTATOC imaging of neuroendocrine tumors: a systematic review and metaanalysis. J Nucl Med. 2017;58(9):1452\u20138. https:\/\/doi.org\/10.2967\/jnumed.117.191197.","journal-title":"J Nucl Med"},{"issue":"2","key":"5170_CR38","doi-asserted-by":"publisher","first-page":"EC08","DOI":"10.7860\/JCDR\/2017\/24350.9381","volume":"11","author":"A Mahadevappa","year":"2017","unstructured":"Mahadevappa A, Krishna SM, Vimala MG. Diagnostic and prognostic significance of Ki-67 immunohistochemical expression in surface epithelial ovarian carcinoma. J Clin Diagn Res. 2017;11(2):EC08-EC12. https:\/\/doi.org\/10.7860\/JCDR\/2017\/24350.9381.","journal-title":"J Clin Diagn Res"},{"key":"5170_CR39","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1200\/JCO.2006.10.1535","volume":"25","author":"D Campana","year":"2007","unstructured":"Campana D, Nori F, Piscitelli L, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol. 2007;25:1967\u201373.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5170_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ygyno.2007.05.020","volume":"107","author":"Y Ohishi","year":"2007","unstructured":"Ohishi Y, Kaku T, Oya M, et al. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls. Gynecol Oncol. 2007;107(1):30\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2007.05.020.","journal-title":"Gynecol Oncol"},{"key":"5170_CR41","unstructured":"Yeh YA. Synaptophysin. PathologyOutlines.com website. https:\/\/www.pathologyoutlines.com\/topic\/stainssynaptophysin.html. Accessed 30 May 2024."},{"issue":"4","key":"5170_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/modpathol.2008.4","volume":"21","author":"LA Kubba","year":"2008","unstructured":"Kubba LA, McCluggage WG, Liu J, et al. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Modern Pathol. 2008;21(4):485\u201390. https:\/\/doi.org\/10.1038\/modpathol.2008.4.","journal-title":"Modern Pathol"},{"key":"5170_CR43","unstructured":"Kankanala VL, Mukkamalla SKR. Carcinoembryonic Antigen. [Updated 2023 Jan 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK578172\/."},{"issue":"4","key":"5170_CR44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/cam4.1003","volume":"6","author":"D Shinmi","year":"2017","unstructured":"Shinmi D, Nakano R, Mitamura K, et al. Novel anticarcino embryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen. Cancer Med. 2017;6(4):798\u2013808.","journal-title":"Cancer Med"},{"issue":"4","key":"5170_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00004347-200110000-00006","volume":"20","author":"QJ Cao","year":"2001","unstructured":"Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2001;20(4):346\u201352. https:\/\/doi.org\/10.1097\/00004347-200110000-00006.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"5170_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090575","volume":"9","author":"P Walentowicz","year":"2014","unstructured":"Walentowicz P, Krintus M, Sadlecki P, et al. Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients. PLoS ONE. 2014;9(3): e90575. https:\/\/doi.org\/10.1371\/journal.pone.0090575.","journal-title":"PLoS ONE"},{"key":"5170_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/PAS.0000000000001641","volume":"45","author":"Q Zou","year":"2021","unstructured":"Zou Q, Zhang L, Cheng Z, et al. INSM1 is less sensitive but more specific than synaptophysin in gynecologic high-grade neuroendocrine carcinomas: an immunohistochemical study of 75 cases with specificity test and literature review. Am J Surg Pathol. 2021;45:147\u201359. https:\/\/doi.org\/10.1097\/PAS.0000000000001641.","journal-title":"Am J Surg Pathol"},{"key":"5170_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152993","volume":"216","author":"JF Chen","year":"2020","unstructured":"Chen JF, Yang C, Sun Y, et al. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: an immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56. Pathol Res Pract. 2020;216: 152993. https:\/\/doi.org\/10.1016\/j.prp.2020.152993.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"5170_CR49","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/IGC.0000000000001243","volume":"28","author":"D Nasioudis","year":"2018","unstructured":"Nasioudis D, Chapman-Davis E, Frey MK, et al. Small cell carcinoma of the ovary: a rare tumor with a poor prognosis. Int J Gynecol Cancer. 2018;28(5):932\u20138. https:\/\/doi.org\/10.1097\/IGC.0000000000001243.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"5170_CR50","first-page":"3091","volume":"35","author":"O Jamy","year":"2015","unstructured":"Jamy O, Yaghmour G, Hare F, et al. Population-based analysis of the clinical features of primary small cell carcinoma of the ovary. Anticancer Res. 2015;35(5):3091\u20135.","journal-title":"Anticancer Res"},{"issue":"2","key":"5170_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000499469","volume":"109","author":"A Rinke","year":"2019","unstructured":"Rinke A, Neary MP, Eriksson J, et al. Health-related quality of life for long-acting octreotide versus placebo in patients with metastatic midgut neuroendocrine tumors in the phase 3 PROMID trial. Neuroendocrinology. 2019;109(2):141\u201351. https:\/\/doi.org\/10.1159\/000499469.","journal-title":"Neuroendocrinology"},{"key":"5170_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/sjmms.sjmms_213_21","volume":"9","author":"ST AlZuheiri","year":"2021","unstructured":"AlZuheiri ST, Dube R, Menezes G, et al. Clinical profile and outcome of Group B streptococcal colonization in mothers and neonates in Ras Al Khaimah, United Arab Emirates: a prospective observational study. Saudi J Med Med Sci. 2021;9:235\u201340.","journal-title":"Saudi J Med Med Sci"},{"key":"5170_CR53","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/medicina60081322","volume":"60","author":"A Fatima","year":"2024","unstructured":"Fatima A, Abuhijleh SA, Fatah A. Infantile neuroaxonal dystrophy: case report and review of literature. Medicina. 2024;60:1322. https:\/\/doi.org\/10.3390\/medicina60081322.","journal-title":"Medicina"},{"issue":"2019","key":"5170_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/EDM-19-0040","volume":"20","author":"S Jhawar","year":"2019","unstructured":"Jhawar S, Lakhotia R, Suzuki M, et al. Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinol Diabetes Metab Case Rep. 2019;20(2019):19\u20130040. https:\/\/doi.org\/10.1530\/EDM-19-0040.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"5170_CR55","doi-asserted-by":"publisher","first-page":"36225","DOI":"10.18632\/oncotarget.16717","volume":"8","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Tian T, Wei Z, et al. The ovarian cancer oncobiome. Oncotarget. 2017;8:36225\u201345. https:\/\/doi.org\/10.18632\/oncotarget.16717.","journal-title":"Oncotarget"},{"issue":"13","key":"5170_CR56","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.2147\/CMAR.S314686","volume":"8","author":"L Pang","year":"2021","unstructured":"Pang L, Yang H, Ning Y, et al. Retrospective analysis of clinicopathological features and prognosis of gynecological small-cell carcinoma. Cancer Manag Res. 2021;8(13):4529\u201340. https:\/\/doi.org\/10.2147\/CMAR.S314686.","journal-title":"Cancer Manag Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05170-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:05:10Z","timestamp":1742371510000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5170"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05170-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It was reviewed by institutional review board. Medical Research Section, Dubai Scientific Research Ethics Committee has also reviewed the proposal and exempted it from further need for ethical approval because of written consent from the patient for a single case report, in line with the policy of the committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}